Ulcerative Colitis Clinical Trials

Showing 5541-5560 of 9,572 trials

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

NCT00143208

This study is designed as an open label evaluation of the efficacy of latanoprost and timolol fixed combination (Xalacom) after 6 month of treatment. Eligible patients may be enrolled at the baseline visit. All current ocular hypotensive therapy must be discontinued at this time. On baseline day, patients eligible for the study will receive Xalacom which is to be instilled in the morning.

GlaucomaOcular Hypertension

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.250 participantsStarted May 2003

Arezzo, Italy • Bari, Italy • Bollate, Italy +18 more locations

COMPLETEDPhase 3

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

NCT00159653

To demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure measurements at 8 AM, 10 AM, 4 PM at weeks 2, 6 and 12.

Glaucoma, Open-AngleOcular Hypertension

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.500 participantsStarted Jul 2005

Phoenix, Arizona, United States • Poway, California, United States • Redding, California, United States +52 more locations

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Related Searches

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

Obstructive Sleep Apnea & Covid-19 Outcomes

Yoga for Youth With IBD: a Pilot Feasibility Study

Risk Literacy Among Portuguese Medical and Dentistry Students

A Volunteer Study to Collect Imaging Data for the Development of the IntelligentUltrasound Anatomy Guide

Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance

Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease

Initial Management of MRONJ Stages I and II, a Clinical Trial With Detection of Salivary Biomarkers

Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells

Propess Versus Prostin for Induction of Labour in Women With Term PROM

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.

Melatonin and Ulcerative Colitis: A Pilot Clinical Trial

Scapular Flap Versus Obturator